The biology of the receptor for advanced glycation end products and its ligands
- 20 December 2000
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1498 (2-3), 99-111
- https://doi.org/10.1016/s0167-4889(00)00087-2
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling PathwaysOnline Journal of Public Health Informatics, 1999
- RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin PolypeptidesCell, 1999
- Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.JCI Insight, 1998
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.JCI Insight, 1996
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.JCI Insight, 1995
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Free radicals and disruption of neuronal ion homeostasis in AD: A role for amyloid β-peptide?Neurobiology of Aging, 1995
- Lipoprotein and receptor interactions in vivoCurrent Opinion in Lipidology, 1995
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.JCI Insight, 1993